{"id":889551,"date":"2026-09-12T16:48:35","date_gmt":"2026-09-12T16:48:35","guid":{"rendered":"https:\/\/www.newsbeep.com\/au\/889551\/"},"modified":"2026-09-12T16:48:35","modified_gmt":"2026-09-12T16:48:35","slug":"asx-healthcare-shares-are-39-higher-since-june-are-you-missing-out","status":"publish","type":"post","link":"https:\/\/www.newsbeep.com\/au\/889551\/","title":{"rendered":"ASX healthcare shares are 39% higher since June. Are you missing out?"},"content":{"rendered":"

S&P\/ASX 200 Index (ASX: XJO) healthcare\u00a0shares<\/a>\u00a0have soared 39% since the sector pivoted just three months ago.<\/p>\n

The\u00a0S&P\/ASX 200 Health Care Index\u00a0(ASX: XHJ) slumped to a 9-year low on 3 June after a terrible 12 months. <\/p>\n

The index fell 39% due to many headwinds<\/a>, including higher costs of living prompting consumers to delay healthcare expenditure. <\/p>\n

Eventually, ASX 200 healthcare shares became too cheap to ignore, and value investors swooped in to capitalise. <\/p>\n

They targeted fallen blue-chip<\/a> stocks at first. <\/p>\n

Sector giant CSL Ltd (ASX: CSL<\/a>) saw its share price skyrocket 32% in just the first month of the rebound. <\/p>\n

Investors were further buoyed by CSL management’s outlook when the company reported its FY26 results<\/a>\u00a0last month. <\/p>\n

This boosted the CSL share price further, and now the stock is up 82% since 3 June. <\/p>\n

Not all healthcare stocks have performed as well, and experts say there are still good opportunities afoot. <\/p>\n

If you’re looking for opportunities in this buoyant sector, here are two buy-rated ASX healthcare small-caps<\/a> from the experts. <\/p>\n

\"Doctor<\/p>\n

Image source: Getty Images<\/p>\n

The SomnoMed share price is 34 cents, down 2.9% today and down 55% over 12 months.<\/p>\n

Top broker Morgans refers to this ASX healthcare share as the “cheaper sleeper”. <\/p>\n

Morgans has a speculative buy recommendation on SomnoMed shares. <\/p>\n

The broker has a 12-month price target of 76 cents on this stock, which implies a potential 127% upside ahead. <\/p>\n

Morgans said: <\/p>\n

The FY26 result<\/a> landed where the July trading update flagged, with revenue of A$114.5m and adjusted EBITDA of A$10.9m (9.6% margin), a touch under our A$11.1m EBITDA forecast. <\/p>\n

The management restructure is now formalised (Karen Borg sole CEO, Greg Knight COO, Nathan Minnich CMO), removing the leadership overhang flagged in July and giving the FY27 growth reinflection case a settled team to execute against. <\/p>\n

With A$16.8m net cash against a A$73m market cap, SOM is now trading on <8x EV\/EBITDA, it’s too cheap.<\/p>\n

Mach7 Technologies Ltd (ASX: M7T<\/a>)<\/p>\n

The Mach7 Technologies share price is 26 cents, down 5.5% today and down 13% over 12 months.<\/p>\n

Morgans has a buy rating on this ASX healthcare share with a 48-cent target. <\/p>\n

This suggests a potential 84% upside ahead.<\/p>\n

Morgans said:<\/p>\n

The market should be broadly comfortable with the result<\/a> given recent trading updates, but new contract delivery remains the key requirement before investors are likely to begin marking the stock materially higher.<\/p>\n

Revenue and OPEX landed broadly in line with guidance, while the NPAT miss was driven by a A$1.9m restructuring charge and a weaker tax benefit rather than deterioration in the core subscription business.<\/p>\n

Moderate increase in target price due to model roll-forward, lower share count, and leaner-than-expected cost base.<\/p>\n

Upside potential to target presents an opportunity but needs new contract momentum to spark renewed interest.<\/p>\n","protected":false},"excerpt":{"rendered":"S&P\/ASX 200 Index (ASX: XJO) healthcare\u00a0shares\u00a0have soared 39% since the sector pivoted just three months ago. The\u00a0S&P\/ASX 200…\n","protected":false},"author":2,"featured_media":889552,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[34],"tags":[64,63,137,500],"class_list":["post-889551","post","type-post","status-publish","format-standard","has-post-thumbnail","category-healthcare","tag-au","tag-australia","tag-health","tag-healthcare"],"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/posts\/889551","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/comments?post=889551"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/posts\/889551\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/media\/889552"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/media?parent=889551"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/categories?post=889551"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/tags?post=889551"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}